Apr 30, 2024
PolyPid Announces Enrollment of 200th Patient in Ongoing SHIELD II Phase 3 Trial Evaluating D-PLEX₁₀₀ for the Prevention of Abdominal Colorectal Surgical Site Infections
Apr 24, 2024
PolyPid to Report First Quarter 2024 Financial Results and Operational Highlights on May 8, 2024
Feb 28, 2024
PolyPid to Participate in Barclays 26th Annual Global Healthcare Conference
Feb 14, 2024
PolyPid Provides Corporate Update and Reports Fourth Quarter and Full Year 2023 Financial Results
Feb 12, 2024
PolyPid Announces Enrollment of the 100th Patient in the Ongoing SHIELD II Phase 3 Trial
Jan 31, 2024
PolyPid to Report Fourth Quarter and Full-Year 2023 Financial Results and Operational Highlights on February 14, 2024
Jan 04, 2024
PolyPid Announces Private Placement for $16 Million in Gross Proceeds
Displaying 11 - 17 of 17